The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.3, 2010-03, pp. : 451-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Semi‐Mechanism‐Based Population Pharmacokinetic Modeling of the Hedgehog Pathway Inhibitor Vismodegib

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 11, 2015-11 ,pp. : 680-689

John Wiley & Sons Inc

Access to resources Recommend Favorite

Young people with non-melanoma skin cancers are at higher risk of other cancers

By Printz Carrie

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2382-2383

Blackwell Publishing

Access to resources Recommend Favorite

Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 580-595

Bentham Science Publishers

Access to resources Recommend Favorite

Hedgehog Signaling and Urological Cancers

Current Drug Targets, Vol. 16, Iss. 3, 2015-01 ,pp. : 258-271

Bentham Science Publishers

Access to resources Recommend Favorite

Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors

Current Drug Targets, Vol. 11, Iss. 11, 2010-11 ,pp. : 1439-1457

Bentham Science Publishers

Access to resources Recommend Favorite